Medications

Best GLP-1 for Weight Loss in 2026: Tirzepatide vs Semaglutide

7 min read17 de abril de 2026Por GLP Spot Editorial Team
Best GLP-1 for Weight Loss in 2026: Tirzepatide vs Semaglutide

If you're researching GLP-1 medications for weight loss, you've probably seen the names: Ozempic, Wegovy, Mounjaro, Zepbound. But which one works best?

The short answer: tirzepatide (Zepbound) currently shows the strongest weight loss results. Let's break down why.

The Two Main Options

GLP-1 medications fall into two categories:

  1. Semaglutide-based: Ozempic, Wegovy, Rybelsus
  2. Tirzepatide-based: Mounjaro, Zepbound

Both work. But tirzepatide has an edge.

Head-to-Head: Tirzepatide vs Semaglutide

Tirzepatide (Zepbound) Semaglutide (Wegovy)
Drug class Dual GIP/GLP-1 agonist GLP-1 agonist only
Avg weight loss 20-22% 15%
Max dose 15 mg weekly 2.4 mg weekly
Nausea rate ~40% ~44%
Injection Once weekly Once weekly

Why Tirzepatide Works Better

Tirzepatide targets two hormones: GIP and GLP-1. Semaglutide only targets GLP-1.

This dual action may explain why tirzepatide produces more weight loss. You get a stronger effect on appetite and blood sugar control.

Weight Loss Numbers

Clinical trial results (at maximum dose, ~68-72 weeks):

Tirzepatide (Zepbound 15 mg):

  • Average: 20-22% body weight loss
  • 30%+ of participants lost 25% or more

Semaglutide (Wegovy 2.4 mg):

  • Average: ~15% body weight loss
  • About half of participants lost 15% or more

Your results will vary. Genetics, starting weight, diet, and exercise all play a role.

Side Effects: How Do They Compare?

Similar side effect profiles:

Most common:

  • Nausea
  • Constipation or diarrhea
  • Decreased appetite
  • Stomach pain

Less common:

  • Vomiting
  • Fatigue
  • Dizziness

Tirzepatide may cause slightly less nausea than semaglutide in some studies, but both cause similar side effects at similar rates.

Side effects are worst when starting and after dose increases. Most people adjust over 4-8 weeks.

Cost Considerations

List prices (before insurance):

  • Zepbound: ~$1,060/month
  • Wegovy: ~$1,349/month
  • Mounjaro: ~$1,023/month
  • Ozempic: ~$968/month

Your actual cost depends entirely on insurance. Some plans cover one but not others. Savings cards can reduce costs for commercially insured patients.

Which Should You Choose?

Consider tirzepatide (Zepbound) if:

  • Weight loss is your main goal
  • You want the highest average weight loss
  • Your insurance covers it

Consider semaglutide (Wegovy) if:

  • Tirzepatide isn't covered
  • You prefer a medication with a longer track record
  • Your doctor recommends it based on your health history

Consider Ozempic or Mounjaro if:

  • You have type 2 diabetes
  • Your insurance covers diabetes medications but not weight loss drugs

The Reality Check

The "best" GLP-1 is the one your insurance covers and your doctor prescribes.

All GLP-1s require lifestyle changes to work best. They're tools, not magic solutions. You still need to eat well and move your body.

Tips for success:

Bottom Line

For pure weight loss potential, tirzepatide (Zepbound) shows the strongest results in clinical trials. But semaglutide (Wegovy) also works well and has a longer safety track record.

The medication that's covered by your insurance and prescribed by your doctor is the best one for you.

Work with your healthcare provider to determine which medication is right for you. Individual results and experiences vary.

Want More GLP-1 Nutrition Tips?

Get weekly recipes and nutrition advice delivered straight to your inbox. No spam, ever.

We respect your privacy. Unsubscribe anytime.